Skip to main content
. 2018 Apr 19;9(3):1149–1167. doi: 10.1007/s13300-018-0424-2

Table 2.

Median rank (95% CrI)

graphic file with name 13300_2018_424_Tab2_HTML.jpg

The highest and second highest median ranks of the primary comparators per outcome are highlighted in green and blue, respectively

AE adverse event, ALBI albiglutide, am morning, BID twice-daily, CFB change from baseline, CrI credible interval, DULA dulaglutide, EXE exenatide, FPG fasting plasma glucose, HbA1c glycated hemoglobin, IGlar insulin glargine, LIRA liraglutide, LIXI lixisenatide, pm evening, QD once-daily, QW once-weekly, SBP systolic blood pressure, SEMA semaglutide, SITA sitagliptin

Secondary comparators